Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
#Bioprocess Technology Market Value Analysis: What Growth Is Expected Over The Forecast Period?#_x000D_
The bioprocess technology market has experienced considerable expansion in recent years. It is anticipated to increase from $28.71 billion in 2025 to $33.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.5%. The historical growth of this market can be attributed to the expansion of biopharmaceutical manufacturing, the increasing use of cell-based therapies, the growth of research and development activities, the rising demand for biologics, and the availability of advanced laboratory infrastructure._x000D_
_x000D_
The bioprocess technology market is set to experience substantial growth over the next few years, with its value forecast to reach $59.03 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.5%. This expansion is primarily driven by increasing investments in biologics and biosimilars, the rising adoption of continuous bioprocessing, the broadening scope of personalized medicine production, a growing commitment to sustainable biomanufacturing, and the enhanced integration of digital process control systems. Key trends anticipated during this period include the wider acceptance of single-use bioprocessing systems, a surging demand for scalable cell culture technologies, the greater incorporation of automation in bioreactors, the evolution of advanced cell line development techniques, and a stronger emphasis on process optimization and yield efficiency._x000D_
_x000D_
#Download A Free Sample Report For Comprehensive Market Insights:#_x000D_
_x000D_
#Bioprocess Technology Market Demand Drivers Creating New Revenue Opportunities_x000D_
The bioprocess technology market is projected to see growth fueled by the expanding prevalence of chronic diseases. A chronic disease is an illness that lasts for three months or longer and can deteriorate over time. Bioprocess technology is vital for the development and production of gene therapies, vaccines, cell culture and fermentation, and monoclonal antibody production, all addressing chronic diseases to push forward advancements in medicine and improve patients’ quality of life. For instance, in January 2023, the National Library of Medicine, a US-based agency, indicated that the population in the US aged 50 and older with at least one chronic condition is expected to increase by 99.5%, reaching 142.66 million by 2050. Thus, the increasing occurrence of chronic diseases is a key driver for the bioprocess technology market’s expansion._x000D_
_x000D_
#Bioprocess Technology Market Segmentation And Category Breakdown#_x000D_
The bioprocess technology market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Cell Culture, Cell Expansion, Flow Cytometry, Cell Line Development, Virus Filtration_x000D_
2) By Application: Biopharmaceuticals, Specialty Products, Industry Chemicals, Environment Management Aid_x000D_
3) By End User: Hospitals, Research labs, Medical Institutions, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture _x000D_
2) By Cell Expansion: Adherent Cell Expansion, Suspension Cell Expansion _x000D_
3) By Flow Cytometry: Cell Analysis, Cell Sorting _x000D_
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development _x000D_
5) By Virus Filtration: Viral Vector Production, Virus Filtration Techniques _x000D_
_x000D_
#Bioprocess Technology Market Innovation Trends Driving Future Development#_x000D_
Prominent companies operating within the bioprocess technology market are developing innovative service options, such as the custom organoid line expansion service, to achieve a competitive edge. This custom organoid line expansion service utilizes proprietary bioreactor and bioprocess technology to enhance the production scale of organoids. For instance, in July 2023, Molecular Devices LLC, a US-based Research and development company, launched its custom organoid line expansion service. This service aids researchers in screening thousands to tens of thousands of drug candidates concurrently using organoids from the same source. It is designed to support cutting-edge drug discovery research and enables the creation of more efficient, reproducible, and scalable patient-derived organoids (PDOs)._x000D_
_x000D_
#Bioprocess Technology Market Competitive Analysis Of Major Industry Participants#_x000D_
Major companies operating in the bioprocess technology market are Sartorius AG; Thermo Fisher Scientific Inc.; Lonza Group AG; F. Hoffmann-La Roche Ltd.; Becton Dickinson and Company; Merck KGa; GE Healthcare; Eppendorf AG; Bio-Rad Laboratories; Catalent Inc.; Advanced Instruments LLC; MilliporeSigma; Repligen Corporation; Danaher Corporation; PerkinElmer Inc.; Applikon Biotechnology; New Brunswick Scientific Co. Inc.; Avid Bioservices; Meissner Filtration Products; 3M; Eppendorf Biochip Systems; Fermenter Bioreactor; Solaris Biotechnology Srl; Aber Instruments; Cytiva _x000D_
_x000D_
#Access The Complete Bioprocess Technology Market Report:#_x000D_
_x000D_
#Bioprocess Technology Market Regional Outlook: Where Are The Largest Opportunities Located?#_x000D_
North America was the largest region in the bioprocess technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioprocess technology market report during the forecast period. The regions covered in the bioprocess technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.